None listed
Conditions
Interventions
Medical Device : For the study group, MegaNuovo is applied after debridement, the control group 1 is performed to negative pressure treatment after the debridement, and the control group 2 is combinat
Sponsors
Yonsei University, Wonju Severance Christian Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Patients aged 19 to less than 90 years of age ? Patients with stage 2~4 pressure ulcers ? Patients who have fully explained the purpose and contents of the test before taking the test and voluntarily signed the written consent (a legal representative can represent him if necessary) ? Patients who can follow-up during the test period
Exclusion criteria
Exclusion criteria: ? HbA1c=12% ? Patients with evidence of active infection including osteomyelitis or cellulitis ? Patients who want surgical treatment ? Pregnant and lactating women (urine hCG test) ? Patients with psychiatric problems ? Patients with infectious diseases, systemic autoimmune diseases (rheumatic diseases, etc.), blood clotting disorders (diagnosed by medical staff through questionnaire and physical examination) ? In case it is judged difficult to conduct clinical trials by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of change in the size of the ulcer at 4 weeks by group | — |
Secondary
| Measure | Time frame |
|---|---|
| The stage of the ulcer ;rate of infection;laboratory test;Proportion of patients with complete healing;The rate of change in the size of the ulcer | — |
Countries
Korea, Republic of
Contacts
Public ContactChae-Eun Yang
Yonsei University Wonju College of Medicine
Outcome results
None listed